308 The Impact of a Value-Based Health Care in Inflammatory Bowel Diseases on Health Care Utilization

2016 ◽  
Vol 150 (4) ◽  
pp. S70-S71 ◽  
Author(s):  
Welmoed K. van Deen ◽  
Martha Skup ◽  
Adriana Centeno ◽  
Natalie E. Duran ◽  
Precious Lacey ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Inflammatory Bowel Diseases ◽  
Care Utilization ◽  
A Value ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
The Impact

scholarly journals A Nationwide 2010–2012 Analysis of U.S. Health Care Utilization in Inflammatory Bowel Diseases

2014 ◽  
Vol 20 (10) ◽  
pp. 1747-1753 ◽  
Author(s):  
Welmoed K. van Deen ◽  
Martijn G. H. van Oijen ◽  
Kelly D. Myers ◽  
Adriana Centeno ◽  
William Howard ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Inflammatory Bowel Diseases ◽  
Care Utilization ◽  
Bowel Diseases ◽  
Inflammatory Bowel

scholarly journals Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases

2017 ◽  
Vol 15 (3) ◽  
pp. 385-392.e2 ◽  
Author(s):  
Julajak Limsrivilai ◽  
Ryan W. Stidham ◽  
Shail M. Govani ◽  
Akbar K. Waljee ◽  
Wen Huang ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Inflammatory Bowel Diseases ◽  
Care Utilization ◽  
Bowel Diseases ◽  
Inflammatory Bowel

scholarly journals The Impact of Psychiatric Comorbidity on Health Care Utilization in Inflammatory Bowel Disease: A Population-based Study

2020 ◽  
Author(s):  
Charles N Bernstein ◽  
Carol A Hitchon ◽  
Randy Walld ◽  
James M Bolton ◽  
Lisa M Lix ◽  
...  
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Health Care Utilization ◽  
Bowel Disease ◽  
Psychiatric Comorbidity ◽  
Care Utilization ◽  
Physician Visits ◽  
Inflammatory Bowel ◽  
Hospital Days ◽  
The Impact

Abstract Background Inflammatory bowel disease (IBD) is associated with an increase in psychiatric comorbidity (PC) compared with the general population. We aimed to determine the impact of PC on health care utilization in persons with IBD. Methods We applied a validated administrative definition of IBD to identify all Manitobans with IBD from April 1, 2006, to March 31, 2016, and a matched cohort without IBD. A validated definition for PC in IBD population was applied to both cohorts; active PC status meant ≥2 visits for psychiatric diagnoses within a given year. We examined the association of active PC with physician visits, inpatient hospital days, proportion with inpatient hospitalization, and use of prescription IBD medications in the following year. We tested for the presence of a 2-way interaction between cohort and PC status. Results Our study matched 8459 persons with IBD to 40,375 controls. On crude analysis, IBD subjects had ≥3.7 additional physician visits, had >1.5 extra hospital days, and used 2.1 more drug types annually than controls. Subjects with active PC had >10 more physician visits, had 3.1 more hospital days, and used >6.3 more drugs. There was a synergistic effect of IBD (vs no IBD) and PC (vs no PC) across psychiatric disorders of around 4%. This synergistic effect was greatest for anxiety (6% [2%, 9%]). After excluding psychiatry-related visits and psychiatry-related hospital stays, there remained an excess health care utilization in persons with IBD and PC. Conclusion Inflammatory bowel disease with PC increases health care utilization compared with matched controls and compared with persons with IBD without PC. Active PC further increases health care utilization.

Trends in U.S. Health Care Spending on Inflammatory Bowel Diseases, 1996-2016

2021 ◽  
Author(s):  
Siddharth Singh ◽  
Alexander S Qian ◽  
Nghia H Nguyen ◽  
Stephanie K M Ho ◽  
Jiyu Luo ◽  
...  
Keyword(s):  
Health Care ◽  
Confidence Interval ◽  
Inflammatory Bowel Diseases ◽  
Temporal Trends ◽  
Age Groups ◽  
Care Utilization ◽  
Health Care Spending ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Global Burden Of Diseases

Abstract Background Inflammatory bowel diseases (IBD) are rising in prevalence and are associated with high health care costs. We estimated trends in U.S. health care spending in patients with IBD between 1996 and 2016. Methods We used data on national health care spending developed by the Institute for Health Metrics and Evaluations for the Disease Expenditure Project. We estimated corresponding U.S. age-specific prevalence of IBD from the Global Burden of Diseases Study. From these 2 sources, we estimated prevalence-adjusted, temporal trends in U.S. health care spending in patients with IBD, stratified by age groups (<20 years, 20-44 years, 45-64 years, ≥65 years) and by type of care (ambulatory, inpatient, emergency department [ED], pharmaceutical prescriptions, and nursing care), using joinpoint regression, expressed as an annual percentage change (APC) with 95% confidence intervals. Results Overall, annual U.S. health care spending on IBD increased from $6.4 billion (95% confidence interval, 5.7-7.4) in 1996 to $25.4 billion (95% confidence interval, 22.4-28.7) in 2016, corresponding to a per patient increase in annual spending from $5714 to $14,033. Substantial increases in per patient spending on IBD were observed in patients aged ≥45 years. Between 2011 and 2016, inpatient and ED care accounted for 55.8% of total spending and pharmaceuticals accounted for 19.9%, with variation across age groups (inpatient/ED vs pharmaceuticals: ages ≥65 years, 57.6% vs 11.2%; ages 45-64 years, 49.5% vs 26.9%; ages 20-44 years, 59.2% vs 23.6%). Conclusions Even after adjusting for rising prevalence, U.S. health care spending on IBD continues to progressively increase, primarily in middle-aged and older adults, with unplanned health care utilization accounting for the majority of costs.

scholarly journals A183 TELEHEALTH USE IN RURAL SASKATCHEWAN AND INFLAMMATORY BOWEL DISEASE OUTCOMES

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 197-199
Author(s):  
M Patterson ◽  
M Gozdzik ◽  
J Peña-Sánchez ◽  
S Fowler
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
Health Care Utilization ◽  
Bowel Disease ◽  
Postal Code ◽  
Care Utilization ◽  
Specialist Care ◽  
Disease Characteristics ◽  
Significant Difference ◽  
Inflammatory Bowel

Abstract Background Appropriate management of inflammatory bowel disease (IBD) often requires multiple specialist appointments per year. Living in rural locations may pose a barrier to regular specialist care. Saskatchewan (SK) has a large rural population. Prior to COVID-19, telehealth (TH) in SK was not routinely used for either patient assessment or follow up. Furthermore, TH was exclusively between hospitals and specific TH sites without direct contact using patient’s personal phones. Aims The objective of this study was to assess the differences in demographics, disease characteristics, outcomes, and health care utilization between patients from rural SK with IBD who used TH and those who did not. Methods A retrospective chart review was completed on all rural patients (postal code S0*) with IBD in SK who were followed at the Multidisciplinary IBD Clinic in Saskatoon between January 2018 and February 2020. Patients were classified as using TH if they had ever used it. Information on demographics, disease characteristics, and access to IBD-related health care in the year prior to their last IBD clinic visit or endoscopy was collected. Data was not collected for clinic visits after March 1, 2020 as all outpatient care became remote secondary to the COVID-19 pandemic. Mean, standard deviations, median and interquartile ranges (IQR) were reported. Mann-Witney U and Chi-Square tests were used to determine differences between the groups. Results In total, 288 rural SK IBD patients were included, 30 (10.4%) used TH and 258 (89.6%) did not. Patient demographics were not significantly different between the two groups; although, there was a statistically significant difference in the proportion of ulcerative colitis patients (17% TH vs. 38% non-TH, p=0.02). The percentage of patients with clinical remission was 87% for TH patients and 74% for non-TH patients (p=0.13). There were no significant differences in health care utilization patterns and biochemical markers of disease, including c-reactive protein (CRP) and fecal calprotectin (FCP) (p>0.05). Conclusions Prior to the pandemic, a small percentage of patients with IBD in rural SK ever used TH. A small proportion of UC patients used TH. No significant differences in disease characteristics, outcomes, or health care utilization were identified. Further study is warranted to identify barriers to use of this technology to tailor care to this patient group and improve access to care, especially now as the COVID-19 pandemic has drastically changed the use of virtual care. Funding Agencies None

The Impact of Behavioral Feeding Intervention on Health Care Utilization

2011 ◽  
Vol 40 (4) ◽  
pp. 282-296 ◽  
Author(s):  
Nancy F. Bandstra ◽  
William B. Crist ◽  
Anne Napier-Phillips ◽  
Gordon Flowerdew
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Care Utilization ◽  
The Impact

scholarly journals PRS14 THE IMPACT OF ASTHMA ON HEALTH CARE UTILIZATION AND EXPENDITURE OF PEDIATRIC PATIENTS

2010 ◽  
Vol 13 (3) ◽  
pp. A198
Author(s):  
X Song ◽  
R Shenolikar ◽  
LA Costa ◽  
J Anderson ◽  
BC Chu
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Pediatric Patients ◽  
Care Utilization ◽  
The Impact
Sign in / Sign up

Export Citation Format

Share Document